COVID-19
Fig. 3 · Panel COVID-19_Score
Panel COVID-19_Score 是同一 Fig. 3 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。
Nina Hertoghs, Sanne Roels, Matthias Brückner, Jerald Sadoff, Barbara L Banbury, Nicholas K Akers, Bryan Howie, Harlan S Robins, Griet A van Roey, Jeroen T B M Tolboom, Veronica V Rezelj, Jenny Hendriks, Hanneke Schuitemaker, Daniel J Stieh, Mathieu Le Gars
EBioMedicine 117 105809
BACKGROUND: While vaccine-induced SARS-CoV-2 antibodies provide partial protection against COVID-19, a significant question remains regarding the role of vaccine-induced T cells in combating COVID-19. The purpose of this study is to investigate whether signatures of the T-cell response contribute to protection against (severe) COVID-19. METHODS: T cell receptor (TCR) sequencing was conducted using pre-vaccination and 29 days post-vaccination PAXgene samples from 396 participants in the phase 3 efficacy trial, ENSEMBLE. The dataset consists of 198 individuals who developed breakthrough COVID-19 infections, including 23 severe cases, and an equal number of matched control subjects. Immunosequencing and subsequent computational analysis was performed to identify SARS-CoV-2 and Spike-specific TCRs to quantify SARS-CoV-2 specific T cell breadth, depth, clonal expansion, and a model test score that describes magnitude of cellular response compared to pre-pandemic controls. FINDINGS: Preliminary analyses demonstrated high concordance and correlation between functional T cell responses measured by a standard intracellular cytokine staining and TCR sequencing metrics. Furthermore, vaccine-elicited T cell responses correlated inversely with the risk of developing severe COVID-19, while no strong relation was observed with overall symptomatic COVID-19 risk. A multivariable analysis including neutralizing antibody data and TCR scores indicated that, in addition to humoural responses, T cell responses contribute to protection against severe COVID-19. INTERPRETATION: Our findings show that higher vaccine-elicited T cell responses are significantly correlated with decreased risk of severe COVID-19, but not with risk of any symptomatic COVID-19. These results represent a direct correlation between vaccine-elicited T cell responses and protection from severe COVID-19. FUNDING: This work was fully funded by Janssen Vaccines & Prevention B.V. The samples were sourced from ENSEMBLE, which was partly funded by Biomedical Advanced Research and Development Authority (BARDA), under other transaction agreement HHSO100201700018C.
1 个 Figure · 2 个 KM 面板
Fig. 3 Univariate correlates of risk analysis for all cases vs. controls for COVID-19 and Spike scores (a) boxplots overlayed with individual data points of the Spike score (left) and the COVID-19 score (right) at D1 and D29, split between cases and controls in the ENSEMBLE trial. (b) Boxplots overlayed with individual data points of the COVID-19 Breadth and depth and Spike breadth and depth at D1 and D29, split between cases and controls. (c) Forest plots indicate Hazard Ratios (HR) per each standard deviation increase of the Spike and COVID-19 scores, 95% Confidence Intervals for the HR, and adjusted p-values (d) Cumulative probability of COVID-19 over the course of the study split by the upper, lower and middle tertile for the COVID-19 score (left) and the Spike score (right), with the 95% confidence intervals indicated by the dotted line.
Fig. 3 · Panel COVID-19_Score
Panel COVID-19_Score 是同一 Fig. 3 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。
Fig. 3 · Panel Spike_score
Panel Spike_score 是同一 Fig. 3 中的独立 KM 子图;人群、终点或分析条件以本 Panel 图注语义为准。
这些图片未产生 KM 曲线结果,不在主页面重复展示。